Johnson & Johnson (NYSE:JNJ) is reportedly facing a new proposed class action lawsuit seeking damages and medical monitoring for women who have developed or may develop cancer due to using the company’s talc products. Most recently, Johnson & Johnson agreed to pay $700 million to resolve a multi-state investigation into its talc-based products. Citing a lawsuit filed on Monday in New Jersey federal court, Reuters notes the lawsuit is the first to seek medical monitoring, which involves regular testing to detect cancer ...